Immunoglobulin Products



Print Friendly

Immunoglobulin Chart

[image: Immunoglobulin Products Chart]

Click to view full-size PDF


IDF MAC Resolution on Product Choice for Immunoglobulin Replacement Therapy

In November 2011, the IDF Medical Advisory Committee wrote a resolution regarding formulary changes that limit a physician’s ability to determine the most appropriate immunoglobulin replacement therapy.  Restricting access of subscribers to only one or two product/formulations of replacement immunoglobulin regardless of the particular product the patient may currently be receiving poses an unjustified safety risk for patients. Read the entire resolution:

IDF MAC Resolution on Product Choice for Immunoglobulin Replacement Therapy – 1/26/11